Verapamil (CAS 52-53-9) — formula C27H38N2O4, molecular weight 454.6.
| CAS Number | 52-53-9 |
|---|---|
| Molecular Formula | C27H38N2O4 |
| Molecular Weight | 454.6 |
| Melting Point | < 25 °C |
| Boiling Point | BP: 245 °C at 0.01 mm Hg |
| LogP | 3.79 |
| Applications | Uses: Anti-Arrhythmia Agents, Calcium Channel Blockers, Vasodilator Agents, MEDICATION, Use (kg) in Switzerland (2009): >1000, Use (kg, approx.) in Germany (2009): >25000, Use (kg) in USA (2002): 207000, Consumption (g per capita) in Switzerland (2009): 0.13, Consumption (g per capita, approx.) in Germany (2009): 0.31, Consumption (g per capita) in the USA (2002): 0.73, Excretion rate: 0.2, Calculated removal (%): 21.5, Drug used for the treatment of hypertension, angina, and cluster headache prophylaxis., Use Classification: Pharmaceuticals, Pharmaceuticals -> Cardiovascular system -> Calcium channel blockers -> Selective calcium channel blockers with direct cardiac effects -> Phenylalkylamine derivatives -> Calcium antagonists, Methods of Manufacturing: Preparation: Belgium patent 615861, Dengel, United States of America patent 3261859 (1962, 1966 both to Knoll)., Veratryl chloride + isopropyl bromide + homoveratrylamine + 1-bromo-3-chloroporpane (dehydrobromination, methylation, amine formation, dehydrochlorination), Formulations, Preparations: Trade Names: Isoptin (Knoll), Securon (Knoll Ltd.), Calan (Searle), Cardibeltin (Pharma Schwarz), Cordilox (Abbott), all preparations contain verapamil hydrochloride., Table: Verapamil Hydrochloride Preparations [Table#4670], Table: Verapamil Hydrochloride Combinations [Table#4671], General Manufacturing Information: Available commercially as the free base or hydrochloride, Ca2+ channel antgonist which is unrelated chemically to nifedipine and nitrendipine. |
Documented applications: Uses: Anti-Arrhythmia Agents, Calcium Channel Blockers, Vasodilator Agents, MEDICATION, Use (kg) in Switzerland (2009): >1000, Use (kg, approx.) in Germany (2009): >25000, Use (kg) in USA (2002): 207000, Consumption (g per capita) in Switzerland (2009): 0.13, Consumption (g per capita, approx.) in Germany (2009): 0.31, Consumption (g per capita) in the USA (2002): 0.73, Excretion rate: 0.2, Calculated removal (%): 21.5, Drug used for the treatment of hypertension, angina, and cluster headache prophylaxis., Use Classification: Pharmaceuticals, Pharmaceuticals -> Cardiovascular system -> Calcium channel blockers -> Selective calcium channel blockers with direct cardiac effects -> Phenylalkylamine derivatives -> Calcium antagonists, Methods of Manufacturing: Preparation: Belgium patent 615861, Dengel, United States of America patent 3261859 (1962, 1966 both to Knoll)., Veratryl chloride + isopropyl bromide + homoveratrylamine + 1-bromo-3-chloroporpane (dehydrobromination, methylation, amine formation, dehydrochlorination), Formulations, Preparations: Trade Names: Isoptin (Knoll), Securon (Knoll Ltd.), Calan (Searle), Cardibeltin (Pharma Schwarz), Cordilox (Abbott), all preparations contain verapamil hydrochloride., Table: Verapamil Hydrochloride Preparations [Table#4670], Table: Verapamil Hydrochloride Combinations [Table#4671], General Manufacturing Information: Available commercially as the free base or hydrochloride, Ca2+ channel antgonist which is unrelated chemically to nifedipine and nitrendipine..
Verapamil is a chemical compound with CAS registry number 52-53-9 and molecular formula C27H38N2O4 (molecular weight 454.6).
CAS number: 52-53-9
Its molecular formula C27H38N2O4 comprises 27 C, 38 H, 2 N, 4 O atoms.
Also known as: Verapamil · 维拉帕米
The CAS registry number of Verapamil is 52-53-9.
Molecular formula C27H38N2O4, molecular weight 454.6.
It is also registered under: Verapamil, 维拉帕米.
Recorded applications: Uses: Anti-Arrhythmia Agents, Calcium Channel Blockers, Vasodilator Agents, MEDICATION, Use (kg) in Switzerland (2009): >1000, Use (kg, approx.) in Germany (2009): >25000, Use (kg) in USA (2002): 207000, Consumption (g per capita) in Switzerland (2009): 0.13, Consumption (g per capita, approx.) in Germany (2009): 0.31, Consumption (g per capita) in the USA (2002): 0.73, Excretion rate: 0.2, Calculated removal (%): 21.5, Drug used for the treatment of hypertension, angina, and cluster headache prophylaxis., Use Classification: Pharmaceuticals, Pharmaceuticals -> Cardiovascular system -> Calcium channel blockers -> Selective calcium channel blockers with direct cardiac effects -> Phenylalkylamine derivatives -> Calcium antagonists, Methods of Manufacturing: Preparation: Belgium patent 615861, Dengel, United States of America patent 3261859 (1962, 1966 both to Knoll)., Veratryl chloride + isopropyl bromide + homoveratrylamine + 1-bromo-3-chloroporpane (dehydrobromination, methylation, amine formation, dehydrochlorination), Formulations, Preparations: Trade Names: Isoptin (Knoll), Securon (Knoll Ltd.), Calan (Searle), Cardibeltin (Pharma Schwarz), Cordilox (Abbott), all preparations contain verapamil hydrochloride., Table: Verapamil Hydrochloride Preparations [Table#4670], Table: Verapamil Hydrochloride Combinations [Table#4671], General Manufacturing Information: Available commercially as the free base or hydrochloride, Ca2+ channel antgonist which is unrelated chemically to nifedipine and nitrendipine..
Independent reference data for Verapamil (CAS 52-53-9), compiled from public chemistry databases.
| CAS Registry Number | 52-53-9 |
|---|---|
| PubChem CID | 2520 |
| Molecular formula | C27H38N2O4 |
| IUPAC name | 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile |
| UNII (FDA) | CJ0O37KU29 |
| Molecular Weight | 454.6 |
|---|---|
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 13 |
| Exact Mass | 454.28315770 |
| Monoisotopic Mass | 454.28315770 |
| Topological Polar Surface Area | 64 |
| Heavy Atom Count | 33 |
| Boiling Point | BP: 245 °C at 0.01 mm Hg |
|---|---|
| Boiling Point | 243-246 °C at 1.00E-02 mm Hg |
| Melting Point | < 25 °C |
| Solubility | 4.47 mg/L |
| LogP | 3.79 |
| LogP | 3.83 |
| Dissociation Constants | 9.07 |
| Dissociation Constants | 8.92 |
| Dissociation Constants | pKa = 8.92 |
| Collision Cross Section | 203.4 Ų [M+H]+ |
VERAPAMIL; 52-53-9; Iproveratril; Dilacoran; Verapamilo; Cardibeltin; Verapamilum; Isoptine; Securon; D-365; Cardiagutt; Dignover; Veramex; Verpamil; Quasar; CP-16533-1
| Reported hazard statements | H301 (100%), H311 (100%), H331 (100%) |
|---|
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
H311 (100%): Toxic in contact with skin [Danger Acute toxicity, dermal]
Verapamil · CAS 52-53-9 · C27H38N2O4. UNII CJ0O37KU29. Boiling Point: BP: 245 °C at 0.01 mm Hg; Boiling Point: 243-246 °C at 1.00E-02 mm Hg; Melting Point: < 25 °C.
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.
中文页面: 维拉帕米